Notably, CB1 and CB2 were detectable in all GBM cells tested, and incubation with synthetic agonists ACEA (CB1) and JWH133 (CB2) caused a reduction of Ki67+ cells in GBM #10 and GBM #23, but not in GBM #4. The gene discussed is CNR1; the disease is glioblastoma.